At its core, l’affaire EpiPen is not about a single drug maker making sky’s-the-limit profits. It’s about how we pay for pharmaceuticals, how we contain price increases, and ultimately, who gets to use the drugs.
Health Insurance and Costs
A reporter explores what Obamacare has meant for the health of DACA recipients and their undocumented family members. For many such families, reform has result in a patchwork quilt of eligibility.
While California's Medicaid expansion has helped provide first-time health insurance to residents throughout the Central San Joaquin Valley, patients living in rural communities still face tremendous obstacles to actually receiving care.
The Federal Trade Commission and California Attorney General have spent more than three years examining the merger proposal to weigh antitrust concerns.
Here we check in with prominent health journalists and experts to see what sites, newsletters and social media feeds they turn to first every morning. This week, we caught up with Charles Ornstein, senior reporter for ProPublica.
"It's our obligation to offer treatment in a manner that's rational and logical," said the county's chief medical officer. "We identify the individuals for initial treatment right now, based on how we can offer the most care to the most people, who are going to benefit from it the most now."
Two rural health researchers from the University of Washington offer their take on how health reform has impacted rural communities, and point to new trends that could improve access and quality of care.
One reporter's intrepid data quest has given reporters nationwide a new look at how their local hospitals rank when it comes to charity care. Check out these datasets for story ideas in your neck of the woods.
A complaint filed with HHS’ Office of Civil Rights alleges that Medi-Cal’s 13 million beneficiaries do not have adequate health care. Seven million of them are Latinos.
How one reporter "fell down a data rabbit hole" while investigating how many Medicaid patients were denied costly hep C drugs, and what she'll do differently next time.